Form 4: Trulieve CEO Receives Stock Grant

Trulieve Cannabis Corp. CEO Kim Rivers receives a grant of 285,360 restricted stock units (RSUs) that will vest in two tranches in December 2026 and 2027.

Summary

• Kim Rivers, CEO of Trulieve Cannabis Corp., was granted 285,360 restricted stock units (RSUs) on August 12, 2025.
• 50% of the RSUs will vest on December 1, 2026, and the remaining 50% will vest on December 1, 2027.
• Each RSU represents a contingent right to receive one subordinate voting share of Trulieve Cannabis Corp.
• Rivers directly holds 159,867 Multiple Voting Shares and indirectly holds 9,867 Multiple Voting Shares through Traunch IV LLC.
• Rivers also holds options to acquire 772,495 Subordinate Voting Shares vested as of December 1, 2024.
• Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis, totaling 16,973,400 Subordinate Voting Shares.

Sentiment

Score: 7

Explanation: The filing is neutral to positive, detailing a standard executive compensation practice. It suggests confidence in the CEO's continued leadership.

Positives

• Grant of 285,360 RSUs to the CEO, aligning her interests with the long-term performance of the company.
• Vesting schedule of the RSUs (50% in December 2026 and 50% in December 2027) encourages long-term commitment.
• CEO's significant holdings in Multiple Voting Shares and stock options demonstrate a strong stake in the company's success.

Negatives

• None apparent from the filing, as it primarily details the grant of RSUs.

Risks

• The filing does not explicitly mention any risks.

Future Outlook

The vesting schedule of the RSUs indicates an expectation of continued service and contribution from the CEO over the next few years.

Management Comments

• The filing does not contain direct quotes from management.

Industry Context

In the cannabis industry, stock grants and options are common incentives to attract and retain top executive talent, aligning their interests with company growth and shareholder value.

Comparison to Industry Standards

• Executive compensation packages in the cannabis industry often include a mix of salary, stock options, and restricted stock units.
• Compared to companies like Curaleaf and Green Thumb Industries, Trulieve's executive compensation structure appears to be in line with industry norms.
• The vesting schedule of the RSUs is typical for executive grants, designed to incentivize long-term performance.

Stakeholder Impact

• Shareholders: The RSU grant aligns the CEO's interests with shareholder value.
• Employees: Demonstrates the company's commitment to retaining key leadership.
• Customers: No direct impact.
• Suppliers: No direct impact.
• Creditors: No direct impact.

Next Steps

• Continued monitoring of executive compensation and its impact on company performance.
• Tracking the vesting of the RSUs and their conversion into subordinate voting shares.

Key Dates

Recommendation

The RSU grant is a standard executive compensation practice and does not significantly alter the investment thesis for Trulieve. A hold recommendation is appropriate pending further developments.

Keywords

Trulieve, Cannabis, Kim Rivers, RSU, Restricted Stock Units, Stock Grant, CEO, Beneficial Ownership, SEC Form 4